SITIME CORP SEC Filings

Form 4 filing for SiTime Corp. (SITM) discloses that Chief Executive Officer and Director Rajesh Vashist executed a single open-market sale (Transaction Code S) on 08 Aug 2025.

• Shares sold: 2,000 common shares
• Sale price: $215.00 per share (approx. $430,000 gross proceeds)
• Direct holdings after sale: 470,763 shares, which include 291,093 unvested RSUs/PBRSUs (88,540 time-based; 202,553 performance-based) as noted in footnote 1.
• Indirect holdings: 1,809 shares in each of two family dynasty trusts and 24,781 shares in Aldebran Constellation LLC, for a total of 28,399 indirectly held shares.
• Total beneficial ownership post-transaction: roughly 499,162 shares.

No derivative securities were reported, and the filing was submitted individually by the reporting person. The form does not state that the trade was executed under a Rule 10b5-1 trading plan.

SiTime (Nasdaq: SITM) filed an 8-K disclosing a firmly underwritten public offering of 1,750,000 common shares at $200.00, targeting $350 million in gross proceeds. Underwriters hold a 30-day option for 262,500 additional shares, lifting potential proceeds to $402.5 million. UBS and Stifel lead a six-bank syndicate; closing is set for June 27 2025 under the company’s automatic shelf (S-3 No. 333-277373). Customary indemnities, covenants and termination rights apply, and Cooley LLP issued the legal opinion (Ex. 5.1).

The raise will bolster liquidity and fund corporate purposes but will increase the outstanding share count, creating immediate dilution for existing holders.

SiTime Corporation (NASDAQ: SITM) has filed a prospectus supplement for an underwritten public offering of 1,750,000 shares of common stock at $200.00 per share, compared with the $203.75 last reported sale price on 25 Jun 2025. Gross proceeds are expected to total $350 million, with underwriting discounts and commissions of $7.00 per share ($12.25 million in total), resulting in net proceeds to the company of $337.75 million before expenses.

The company has granted the underwriters a 30-day option to purchase up to an additional 262,500 shares (15% of the base offering), which, if exercised in full, would raise further gross proceeds of up to $52.5 million. The shares are expected to be delivered to investors on or about 27 Jun 2025. UBS Investment Bank and Stifel are acting as joint book-running managers, with Needham & Company, Goldman Sachs & Co. LLC, Raymond James and Roth Capital Partners also participating in the syndicate.

The filing is made under the company’s automatic shelf registration statement on Form S-3 (effective 26 Feb 2024). Sections on Use of Proceeds, Dilution, and Risk Factors are referenced but not detailed in the excerpt, so the specific application of funds and pro-forma capital structure are not disclosed here. Investors should review the full prospectus for additional information, including risk considerations and forward-looking statements.

SiTime (Nasdaq: SITM) filed a 424B5 prospectus supplement announcing an underwritten public offering of $350 million in common stock.

The company intends to issue roughly 1,506,413 shares at an assumed price of $232.34—the last reported sale price on 23 June 2025. Underwriters UBS Investment Bank, Stifel and Needham & Company have a 30-day option to buy up to an additional $52.5 million of shares. Core sections include Risk Factors (S-9), Use of Proceeds (S-13), Dilution (S-14) and Capitalization (S-15). Neither the SEC nor state regulators have yet approved or disapproved the securities.

The prospectus stresses that investing in the shares involves risk and potential dilution; delivery of the shares is expected on or about a closing date to be set in 2025. Investors should review the detailed risk factors and dilution calculations before committing capital.